Petros Pharmaceuticals, Inc. (PTPI)
USD 0.35
(-29.78%)
USD 0.35
(-29.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.62 Million | -12.79 Million | -11.86 Million | -15.3 Million | 2.53 Million | 8.02 Million |
| Net Income | -8.16 Million | -20.03 Million | -8.98 Million | -20.58 Million | -32.51 Million | -32.47 Million |
| Depreciation & Amortization | 3.41 Million | 5.59 Million | 6.87 Million | 6.66 Million | 5.29 Million | 8.06 Million |
| Deferred income taxes | 306.17 Million | - | -9.48 Million | -1.43 Million | -645.86 Thousand | -6940.00 |
| Stock-based compensation | 417.23 Thousand | 1.19 Million | 1.3 Million | - | - | - |
| Change in working capital | 624.91 Thousand | -3.3 Million | -1.76 Million | -5.6 Million | 13.09 Million | 4.93 Million |
| Other non-cash items | -310.09 Million | 3.74 Million | 186.82 Thousand | 2.01 Million | 11.89 Million | 42.54 Million |
| Investing Cash Flow | - | - | - | -4633.00 | -71.54 Thousand | -1.87 Million |
| Investments in PPE | -1.00 | - | - | -4633.00 | -71.54 Thousand | -1.87 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -4.63 Million | - | - |
| Financing Cash Flow | 11.53 Million | -1.62 Million | 18.56 Million | 30.3 Million | -3.1 Million | -2.54 Million |
| Debt repayment | -1.46 Million | -1.62 Million | -7.18 Million | -6.71 Million | -6.01 Million | -2.54 Million |
| Dividends payments | -556.73 Million | - | - | - | - | - |
| Common Stock Repurchased | -1.99 Million | - | - | - | - | - |
| Common Stock Issuance | 15 Million | 3000.00 | 21.74 Million | 21.56 Million | 2.9 Million | - |
| Other Financing Activities | 15 Million | -3000.00 | 4.01 Million | 15.45 Million | -3.1 Million | - |
| Accounts receivables | -144.13 Thousand | 515.95 Thousand | 2.54 Million | -2.75 Million | 932.88 Thousand | 1.95 Million |
| Accounts payables | -93.14 Thousand | -2.75 Million | -1.05 Million | 2.22 Million | 2.02 Million | -965.04 Thousand |
| Inventory | 273.61 Thousand | -835.31 Thousand | 412.74 Thousand | 728.28 Thousand | 2.55 Million | 96.57 Thousand |
| Other working capital | 588.58 Thousand | -231.14 Thousand | -3.67 Million | -5.8 Million | 7.57 Million | 3.85 Million |
| Cash at beginning of period | 9.42 Million | 23.84 Million | 17.13 Million | 2.14 Million | 2.79 Million | -803.21 Thousand |
| Cash at end of period | 13.33 Million | 9.42 Million | 23.84 Million | 17.13 Million | 2.14 Million | 2.79 Million |
| Capital Expenditure | -1.00 | - | - | -4633.00 | -71.54 Thousand | -1.87 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3.91 Million | -14.42 Million | 6.7 Million | 14.99 Million | -648.31 Thousand | 3.59 Million |
| Free Cash Flow | -7.62 Million | -12.79 Million | -11.86 Million | -15.3 Million | 2.46 Million | 6.14 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -662.02 Thousand | -2.16 Million | -8.16 Million | 318.15 Thousand | -4.54 Million | -2.54 Million |
| Depreciation & Amortization | 754.66 Thousand | 753.52 Thousand | 3.41 Million | 934.79 Thousand | 826.79 Thousand | 826.79 Thousand |
| Deferred income taxes | - | - | 306.17 Million | -5.36 Million | -1.9 Million | -41.01 Thousand |
| Stock-based compensation | 116.83 Thousand | 290.38 Thousand | 417.23 Thousand | 212.73 Thousand | 30.84 Thousand | 43.31 Thousand |
| Change in working capital | -278.78 Thousand | 1.75 Million | 624.91 Thousand | 1.62 Million | -1.79 Million | 1.13 Million |
| Other non-cash items | 1.09 Million | -759.69 Thousand | -310.09 Million | 19.61 Thousand | 3.69 Million | 11.52 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 2.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -1.95 Million | -1.12 Million | 11.53 Million | -2.37 Million | 11.08 Million | -363.2 Thousand |
| Debt repayment | -379.79 Thousand | - | -1.46 Million | -374.17 Thousand | -368.64 Thousand | -363.2 Thousand |
| Dividends payments | - | -601.12 Million | -556.73 Million | -556.73 Million | - | - |
| Common Stock Repurchased | -1.57 Million | -1.12 Million | -1.99 Million | - | - | - |
| Common Stock Issuance | - | - | 15 Million | 11.07 Billion | 11.08 Million | - |
| Other Financing Activities | -1.95 Million | -520.29 Thousand | 15 Million | -1.99 Million | 368.64 Thousand | -363.2 Thousand |
| Accounts receivables | 154.7 Thousand | 320.26 Thousand | -144.13 Thousand | 753.15 Thousand | -426.3 Thousand | -145.37 Thousand |
| Accounts payables | -1.34 Million | 424 Thousand | -93.14 Thousand | 358.19 Thousand | -428.67 Thousand | -74.62 Thousand |
| Inventory | 128.61 Thousand | 12.81 Thousand | 273.61 Thousand | 336.8 Thousand | -96.45 Thousand | 88.35 Thousand |
| Other working capital | 784.05 Thousand | 971.38 Thousand | 588.58 Thousand | 176.03 Thousand | -839.45 Thousand | 1.26 Million |
| Cash at beginning of period | 11.08 Million | 13.33 Million | 9.42 Million | 17.96 Million | 7.38 Million | 8.32 Million |
| Cash at end of period | 7.46 Million | 11.08 Million | 13.33 Million | 13.33 Million | 7.39 Million | 7.38 Million |
| Capital Expenditure | 2.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3.62 Million | -2.25 Million | 3.91 Million | -4.63 Million | 12.32 Thousand | -935.27 Thousand |
| Free Cash Flow | -1.66 Million | -1.13 Million | -7.62 Million | -2.25 Million | -3.69 Million | -572.07 Thousand |
MDMP
BFCH
WM
BA
603398
AOECF